Does the addition of corticosteroids or infliximab to IVIg reduce progression in CAA size in high-risk patients with Kawasaki disease and baseline CAA?
Adjunctive therapy with corticosteroids or infliximab added to IVIg may reduce the progression of coronary artery aneurysms in high-risk patients with Kawasaki disease.
Among a high-risk group of patients with Kawasaki disease with CAA on baseline echocardiography, those treated with corticosteroids or infliximab in addition to IVIg had less progression in CAA size compared with those treated with IVIg alone. Prospective randomized trials are needed to determine the best adjunctive treatment of patients who present with CAA.
Dionne et al. (Thu,) studied this question.